Pacira appoints Frank D. Lee as CEO effective Jan 2, 2024; Stack retires to advisory role

Pacira BioSciences, Inc.

Frank Lee named CEO and Board member, effective Jan 2, 2024; prior CEO of Forma Therapeutics.
David Stack retires as CEO and Chairman, remains as advisor through August 2025.
Paul Hastings, Lead Independent Director, elected Chair of the Board effective Jan 2, 2024.
Lee's compensation: $900k base salary, 85% bonus target, 692,512 options, 99,520 RSUs as inducement awards.
Pacira Amended 2014 Inducement Plan to reserve 817,093 shares; term extended to Dec 20, 2033.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Stack

Chief Executive Officer

PCRX · Pacira BioSciences, Inc.

Effective: 2024-01-02
Successor: Frank Lee
Filed: December 21, 2023, 6:59 PM ET

David Stack informed the Board of Directors (the "Board") of Pacira BioSciences, Inc. (the "Company") that he intended to retire as Chief Executive Officer of the Company and as a member of the Board effective immediately following the appointment of his successor as Chief Executive Officer.

Appointed

Frank Lee

Chief Executive Officer

PCRX · Pacira BioSciences, Inc.

Effective: 2024-01-02
Filed: December 21, 2023, 6:59 PM ET

the Board appointed Frank Lee as Chief Executive Officer of the Company and as a member of the Board, effective January 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

David Stack retired as Chief Executive Officer at Pacira BioSciences, Inc..

Action: retired
Role: Chief Executive Officer

Exact text from the filing

David Stack informed the Board of Directors (the "Board") of Pacira BioSciences, Inc. (the "Company") that he intended to retire as Chief Executive Officer of the Company and as a member of the Board effective immediately following the appointment of his successor as Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Frank Lee was appointed as Chief Executive Officer at Pacira BioSciences, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

the Board appointed Frank Lee as Chief Executive Officer of the Company and as a member of the Board, effective January 2, 2024.

View on SEC.gov

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-23-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.